Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

VIVA Board Members’ Latest Paper on Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis Published in JACC

February 20, 2020

VIVA Physicians, a leader in education and advocacy, convened a diverse coalition of stakeholders to address timely issues in peripheral arterial disease: care, reimbursement, and industry innovation. Stakeholders at the Vascular Leader’s Forum in Washington, DC, included representatives from major medical societies, U ...

News & Updates

Final Five Unpublished Late-Breaking Clinical Trial Results Announced at VIVA19

November 6, 2019

LAS VEGAS, 11/6/19 -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas. Below are highlights ...

News & Updates

New Round of Unpublished Clinical Trial Results Announced at VIVA19

November 6, 2019

LAS VEGAS, 11/6/19 -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the third round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas. Below are highlights ...

News & Updates

Five More Late-Breaking Clinical Trials Announced at VIVA19

November 5, 2019

Five More Late-Breaking Clinical Trials Announced at VIVA19 LAS VEGAS, 11/5/19 -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the second round of 21 highly anticipated late-breaking clinical trial results ...

News & Updates

First Round of Late-Breaking Clinical Trial Results Announced at VIVA19

November 5, 2019

LAS VEGAS, Nov. 5, 2019 /PRNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the first round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas. Below ...

Load More